Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects

NCT01873950 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

FED

Sponsor class

Conditions

Drug-induced Surface ECG Changes

Interventions

DRUG: Ranolazine
DRUG: Dofetilide
DRUG: Verapamil
DRUG: Quinidine sulfate
DRUG: Placebo

Sponsor

Food and Drug Administration (FDA)

Collaborators

[object Object]